MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 13.574
EU - Europa 10.469
AS - Asia 2.494
SA - Sud America 120
OC - Oceania 75
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 17
Totale 26.822
Nazione #
US - Stati Uniti d'America 13.377
IT - Italia 5.703
GB - Regno Unito 1.909
SE - Svezia 861
SG - Singapore 711
CN - Cina 682
DE - Germania 477
UA - Ucraina 334
FR - Francia 325
TR - Turchia 305
HK - Hong Kong 281
FI - Finlandia 268
BG - Bulgaria 155
JP - Giappone 135
CA - Canada 96
IE - Irlanda 92
IN - India 87
MX - Messico 79
AU - Australia 68
ID - Indonesia 67
NL - Olanda 63
RU - Federazione Russa 46
VN - Vietnam 39
PK - Pakistan 37
PL - Polonia 37
BR - Brasile 36
AR - Argentina 32
CH - Svizzera 30
TN - Tunisia 30
KR - Corea 29
LT - Lituania 29
BE - Belgio 28
MY - Malesia 27
IR - Iran 25
CL - Cile 21
ES - Italia 21
BZ - Belize 18
RO - Romania 17
EG - Egitto 16
EU - Europa 16
HU - Ungheria 14
PH - Filippine 13
SA - Arabia Saudita 13
TW - Taiwan 12
CO - Colombia 11
PE - Perù 11
AT - Austria 10
PT - Portogallo 10
ZA - Sudafrica 9
NZ - Nuova Zelanda 7
IL - Israele 6
JO - Giordania 6
LU - Lussemburgo 6
RS - Serbia 6
DK - Danimarca 5
DZ - Algeria 5
EC - Ecuador 5
KE - Kenya 5
GR - Grecia 4
IQ - Iraq 4
NO - Norvegia 4
CZ - Repubblica Ceca 3
MA - Marocco 3
AL - Albania 2
BD - Bangladesh 2
BO - Bolivia 2
GT - Guatemala 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
SI - Slovenia 2
TH - Thailandia 2
UG - Uganda 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MM - Myanmar 1
MZ - Mozambico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
VA - Santa Sede (Città del Vaticano) 1
Totale 26.822
Città #
Santa Clara 1.890
Fairfield 1.722
Southend 1.515
Woodbridge 941
Chandler 917
Ashburn 890
Houston 735
Wilmington 584
Singapore 583
Seattle 579
Jacksonville 564
Ann Arbor 531
Cambridge 530
Nyköping 513
Milan 406
Dearborn 387
Rome 356
Hong Kong 262
Modena 217
Helsinki 181
San Diego 179
Beijing 178
Izmir 175
New York 161
Sofia 150
Princeton 147
Redwood City 132
Eugene 113
Florence 96
Bari 87
London 87
Palermo 87
Bologna 84
Bremen 77
Falls Church 71
Naples 70
Catania 68
Dublin 61
Jakarta 60
Los Angeles 53
Shanghai 52
Genoa 50
Boardman 48
Tokyo 48
Des Moines 47
Turin 47
Perth 46
Padova 45
Frankfurt am Main 41
Verona 41
San Jose 40
Chicago 37
Cagliari 36
Dong Ket 30
Salerno 28
Guangzhou 27
Parma 27
Norwalk 26
Ottawa 26
Munich 25
Messina 24
Toronto 23
Trento 23
Brescia 22
Reggio Emilia 22
Bergamo 20
Livorno 20
Brussels 19
Dallas 19
Napoli 19
Pescara 19
Belize City 18
Monza 18
Pisa 18
Reggio Nell'emilia 18
Torino 18
Caserta 17
Hounslow 17
Nanjing 17
Atlanta 16
Council Bluffs 16
Mountain View 16
Mumbai 16
Paris 16
São Paulo 16
Treviso 16
Jinan 15
Kunming 15
Legnano 14
Mexico City 14
Phoenix 14
Reggio Calabria 14
Trieste 14
Venice 14
Amsterdam 13
Buenos Aires 13
Cinisello Balsamo 13
Hefei 13
Perugia 13
Puebla City 13
Totale 17.881
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.181
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.081
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 972
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 662
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 389
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 298
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 284
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 270
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 268
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 258
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 252
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 247
Current treatment of hepatitis C-associated rheumatic diseases. 239
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 235
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 235
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 226
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 226
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 226
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 222
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 219
Aortic pulse wave velocity measurement in systemic sclerosis patients. 215
Cardiac Involvement in Systemic Vasculitis 211
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 210
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 206
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 201
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 200
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 199
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 196
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 195
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 194
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 193
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 190
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 190
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 188
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 188
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 187
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 186
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 183
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 179
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 179
Scleroderma digital ulcers complicated by infection with fecal pathogens. 178
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 174
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 173
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 173
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 173
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 173
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 172
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 167
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 166
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 165
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 165
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 164
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 164
Procedural pain management in the treatment of scleroderma digital ulcers 163
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 162
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 161
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 160
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 159
Nailfold videocapillaroscopy in antisynthetase syndrome 159
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 158
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 157
Osteomyelitis complicating scleroderma digital ulcers. 156
Platelet gel in the treatment of severe scleroderma skin ulcers. 154
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 154
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 153
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 151
Cardiovascular risk and prostanoids in systemic sclerosis 150
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 150
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 150
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 150
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 148
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 147
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 147
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 147
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 147
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 146
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 146
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 145
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 144
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 143
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. 142
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 138
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 138
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 137
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 134
Mixed cryoglobulinemia syndrome: where are we going to? 133
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 132
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 132
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 131
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 130
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 129
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 127
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 126
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 126
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 126
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 124
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 124
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 123
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 120
Acute exacerbation of interstitial lung disease associated with rheumatic disease 119
Totale 22.785
Categoria #
all - tutte 111.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.700 0 0 0 0 0 630 540 503 430 201 217 179
2020/20214.266 333 128 297 365 448 404 370 550 297 458 306 310
2021/20223.473 193 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.236 221 274 279 454 574 346 355 548 151 240 342 452
2024/20253.593 332 195 231 581 1.518 736 0 0 0 0 0 0
Totale 27.253